The Genetic Engineering Approval Committee (GEAC) has already held two meetings to discuss the proposal to allow commercial cultivation of a GM hybrid variety DMH-11 of the mustard plant developed by Delhi University's Centre for Genetic Manipulation of Crop Plants (CGMCP).
In its February 5 meeting, CGMCP was to prepare a Risk Assessment and Risk Management (RARM) document and submit within two weeks. It had also recommended a long procedure for "further review and consultation" on the biosafety data.
"By comparing DMH-11 with very old checks or comparators, the crop developers are trying to show exaggerated benefits. It has not been compared with other hybrids like DMH-1," claimed National Academy of Agricultural Sciences (NAAS) Fellow Sharad Pawar in a press conference.
Alleging that DMH-11 testing was rigged to enable claims of yield benefits, Coalitions said: "However, compared with other extensively tested cultivators, GM mustard actually produces 10.4 per cent to 27.5 per cent lesser yields. Regulatory assessment should focus not only on risks which are being under-reported but also on benefits which are falsely-constructed."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
